| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/10/2000 | CA2525555A1 Rapidly disintegrable solid preparation |
| 02/10/2000 | CA2339301A1 Hdpbo81 nucleic acids and polypeptides |
| 02/10/2000 | CA2339123A1 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| 02/10/2000 | CA2338764A1 Substituted anilide compounds and methods |
| 02/10/2000 | CA2338697A1 Compounds and methods |
| 02/10/2000 | CA2338465A1 Methods and compositions for treating gastro-esophageal reflux disease |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2338001A1 Gastrointestinal bacterial antibody factories |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335654A1 Methods of using a somatostatin analogue |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | CA2304596A1 A medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 02/09/2000 | EP0977758A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 02/09/2000 | EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 02/09/2000 | EP0977751A1 Somatostatin agonists |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977743A1 Protease inhibitors |
| 02/09/2000 | EP0977741A1 Substituted phenyl derivatives, their preparation and use |
| 02/09/2000 | EP0977737A1 Crf antagonistic quino- and quinazolines |
| 02/09/2000 | EP0977733A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/09/2000 | EP0977568A1 Benzocycloheptathiophene compounds |
| 02/09/2000 | EP0977565A1 Pharmaceutical composition |
| 02/09/2000 | EP0977558A2 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 02/09/2000 | EP0977557A1 Pellet-type formulation intended for treating the intestinal tract |
| 02/09/2000 | EP0977482A1 IDENTIFICATION OF POLYNUCLEOTIDES ENCODING NOVEL $i(HELICOBACTER) POLYPEPTIDES IN THE $i(HELICOBACTER) GENOME |
| 02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 02/09/2000 | EP0651652B1 Treatment for sensitive teeth |
| 02/09/2000 | CN1244112A Material intended to remineralise organomineral tissues |
| 02/09/2000 | CN1243743A Medicine for treating chronic hepatism and its preparing process |
| 02/09/2000 | CN1243739A Medicine 'Jiuganlin' for treating hepatism |
| 02/09/2000 | CN1243738A Medicine 'Weikangsan' for treating gastrosis |
| 02/09/2000 | CN1243737A Medicinal capsule for treating stomach-ache |
| 02/09/2000 | CN1243732A Chinese medicine 'Baoeryin' and its preparing process |
| 02/09/2000 | CN1049217C 1,5-benzodiazepine derivatives |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022971 Azetidines |
| 02/08/2000 | US6022899 Effective inhibitors of the cellular sodium proton antiporter |
| 02/08/2000 | US6022898 Metalloproteinase inhibitors |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022880 Substituted pyridylamino indoles |
| 02/08/2000 | US6022873 Metalloproteinase inhibitors |
| 02/08/2000 | US6022694 Assay for ligands to tyrosine kinase receptors |
| 02/08/2000 | CA2150016C Pyrrolopyrimidines as crf antagonists |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same |
| 02/03/2000 | WO2000005269A1 Polymer complexes of glucuronoglucanes |
| 02/03/2000 | WO2000005260A1 Peptide analogues of pacap |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005249A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | WO2000005225A1 Biphenyl derivatives |
| 02/03/2000 | WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor |
| 02/03/2000 | WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
| 02/03/2000 | WO2000004939A1 Dental pin |
| 02/03/2000 | WO2000004937A1 Flat flexible materials |
| 02/03/2000 | WO2000004925A1 Slow release formulations comprising anionic polysaccharide |
| 02/03/2000 | WO2000004924A1 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004907A1 An antilipemic formulation |
| 02/03/2000 | WO2000004904A1 Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof |
| 02/03/2000 | WO2000004891A2 Anti-ulcer composition |
| 02/03/2000 | WO2000004882A1 Formulations of anionic polysaccharides |
| 02/03/2000 | WO2000004877A1 Suppository formulations comprising anionic polysaccharide |
| 02/03/2000 | WO1999056772A3 Hepatitis vaccine |
| 02/03/2000 | DE19834713A1 Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New phenylethylamine derivatives, processes for their preparation and their use as medicaments |
| 02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
| 02/03/2000 | CA2338209A1 Biphenyl derivatives |
| 02/03/2000 | CA2336238A1 Synthetic peptides and methods of use for autoimmune disease therapies |
| 02/03/2000 | CA2335341A1 Peptide analogues of pacap |
| 02/02/2000 | EP0975760A1 Motilin homologs |
| 02/02/2000 | EP0975759A1 Human tumor-associated kazal inhibitor |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975662A1 Hepatitis c ns3 protease inhibitors |
| 02/02/2000 | EP0975650A1 Oligomers which inhibit expression of collagen genes |
| 02/02/2000 | EP0975633A1 5,6,7-trisubstituted-4-aminopyridol 2,3-d]pyrimidine compounds |
| 02/02/2000 | EP0975631A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands |
| 02/02/2000 | EP0975623A2 Indazole amide compounds as serotoninergic agents |
| 02/02/2000 | EP0975612A1 Protease inhibitors |
| 02/02/2000 | EP0975589A2 Dialkyl ureas as calcitonin mimetics |
| 02/02/2000 | EP0975380A2 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 02/02/2000 | EP0975361A1 Methods of modulating immune coagulation |
| 02/02/2000 | EP0975360A2 Bovine respiratory and enteric coronovirus as a vaccine |
| 02/02/2000 | EP0975344A1 Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, motion sickness and vertigo |
| 02/02/2000 | EP0975327A1 Use of 5ht3 antagonists for promoting intestinal lavage |
| 02/02/2000 | EP0839205B1 Liver-specific adenovirus expression vector |
| 02/02/2000 | EP0767794B1 Phosphinic acid derivatives |
| 02/02/2000 | EP0713529B1 Growth differentiation factor of the TGF-B family |
| 02/02/2000 | CN1243512A New process |
| 02/02/2000 | CN1243510A Tricyclicbenzo [3] isoindole and benzo (h) isoquinoline |
| 02/02/2000 | CN1243507A Bis-sulfonomides hydroxamic acids as MMP inhibitors |
| 02/02/2000 | CN1243443A Fresh rehmannia root extract for proliferation of bifidobactor and extraction method thereof |
| 02/02/2000 | CN1243442A Pharmaceutical and alimentary compositions containing bacteria of the genus acetobacter |
| 02/02/2000 | CN1243437A Use of dichlorobenzyl alchol for preparing a preparation for topical treatment of inflammation and preparation containing dichlorobenzyl alchol |
| 02/02/2000 | CN1242999A Pure natural health-care article for eliminating smoke harm |
| 02/02/2000 | CN1048986C Heterocyclic compounds and their preparation and use |
| 02/01/2000 | US6020384 Solid oral unit dosage form; therapy of liver disorders |
| 02/01/2000 | US6020366 Butyric acid matrix metalloproteinase inhibitors |
| 02/01/2000 | US6020363 Isocoumarin derivatives and use thereof in drugs |
| 02/01/2000 | US6020358 Substituted phenethylsulfones and method of reducing TNFα levels |
| 02/01/2000 | US6020356 Pharmaceutical composition for the treatment of autoimmune diseases |